Primary antiretroviral drug resistance in newly human immunodeficiency virus-diagnosed individuals testing anonymously and confidentially

Microbial Drug Resistance

Volumn 17, Issue 2, 2011, Pages 283-289

  Markovitz, Amanda R ^a,b   Thibault, Christina S ^c   Brandauer, Peter W ^d   Buskin, Susan E ^c,e  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Blue Cross Blue Shield of Michigan Cardiovascular Consortium   (United States)

^c PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^d Air Pollution Control Division   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADOLESCENT; ADULT; ANONYMOUS TESTING; ANTIVIRAL RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONFIDENTIALITY; DEMOGRAPHY; FEMALE; GENOTYPE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; UNITED STATES; VIRUS MUTATION;

ADOLESCENT; ADULT; ANONYMOUS TESTING; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COLORADO; CONFIDENTIALITY; DRUG RESISTANCE, VIRAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE; WASHINGTON;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79957649473     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2010.0066     Document Type: Article

References (27)

1. Beddows, S., S. Galpin, S.H. Kazmi, A. Ashraf, A. Johargy, A.J. Frater, N. White, R. Braganza, J. Clarke, M. McClure, and J.N. Weber. 2003. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes. J. Med. Virol. 70:337-342. (Pubitemid 36638044)
2. Bindman, A.B., D. Osmond, F.M. Hecht, J.S. Lehman, K. Vranizan, D. Keane, and A. Reingold. 1998. Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group. JAMA 280:1416-1420. (Pubitemid 28496048)
3. Centers for Disease Control and Prevention (CDC). 1999. Anonymous or confidential HIV counseling and voluntary testing in federally funded testing sites-United States, 1995-1997. Morb. Mortal. Wkly. Rep. 48:509-513.
4. Centers for Disease Control and Prevention (CDC). 2003. Late versus early testing of HIV-16 Sites, United States, 2000-2003. Morb. Mortal. Wkly. Rep. 52:581-586.
5. Centers for Disease Control and Prevention (CDC) 2006. AIDS by Region, 2006. Available at www.cdc.gov/hiv/topics/surveillance/resources/slides/aids- regional/index.htm Accessed 1/18/11.
6. Fehrs, L.J., D. Fleming, L.R. Foster, R.O. McAlister, V. Fox, S. Modesitt, and R. Conrad. 1988. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet 2:379-382.
7. Gandhi, R.T., A. Wurcel, E.S. Rosenberg, M.N. Johnston, N. Hellmann, M. Bates, M.S. Hirsch, and B.D. Walker. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin. Infect. Dis. 37:1693-1698.
8. Hall, H.I., R. Song, P. Rhodes, J. Prejean, Q. An, L.M. Lee, J. Karon, R. Brookmeyer, E.H. Kaplan, M.T. McKenna, R.S. Janssen, and HIV Incidence Surveillance Group. 2008. Estimation of HIV incidence in the United States. JAMA 300:520-529.
9. Helms, D.J., H.S. Weinstock, K.C. Mahle, K.T. Bernstein, B.W. Furness, C.K. Kent, C.A. Rietmeijer, A.M. Shahkolahi, J.P. Hughes, and M.R. Golden. 2009. HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance. J. Acquir. Immune Defic. Syndr. 50:320-326.
10. Hertz-Picciotto, I., L.W. Lee, and C. Hoyo. 1996. HIV test-seeking before and after the restriction of anonymous testing in North Carolina. Am. J. Public Health 86:1446-1450. (Pubitemid 26346608)
11. Hirano, D., G.A. Gellert, K. Fleming, D. Boyd, S.J. Englender, and H. Hawks. 1994. Anonymous HIV testing: the impact of availability on demand in Arizona. Am. J. Public Health. 84:2008-2010.
12. Kegeles, S.M., J.A. Catania, T.J. Coates, L.M. Pollack, and B. Lo. 1990. Many people who seek anonymous HIVantibody testing would avoid it under other circumstances. AIDS 4:585-588. (Pubitemid 20215033)
13. Kellerman, S.E., A. Drake, A. Lansky, and R.M. Klevens. Use of and exposure to HIV prevention programs and services by persons at high risk for HIV. AIDS Patient Care STDS 20:391-398.
14. Kim, D., W. Wheeler, J. Johnson, J. Prejean, W. Heneine, I. Hall, and VARHS Surveillance Coordinators. Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly-Diagnosed HIV-1-Infected Persons, US, 2007. Abstract presented at the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 16-19. Abrstract no. 580.
15. Levi, I., B. Modan, T. Blumstein, O. Luxenburg, T. Yehuda-Cohen, B. Shasha, A. Lotan, A. Bundstein, A. Barzilai, and E. Rubinstein. 2001. Characteristics of clients attending confidential versus anonymous testing clinics for human immunodeficiency virus. Isr. Med. Assoc. J. 3:184-187. (Pubitemid 32432966)
16. Linley, L., and C. Reed. 2004. Applicability of Population-Based STARHS HIV Incidence Measure in Determining Recency of Individual Infection Among Patients Attending STD Clinics. Abstract presented at the 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 8-11. Abstract no. 854.
17. Little, S.J., S.D. Frost, J.K. Wong, D.M. Smith, S.L. Pond, C.C. Ignacio, N.T. Parkin, C.J. Petropoulos, and D.D. Richman. 2008. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J. Virol. 82:5510-5518. (Pubitemid 351705258)
18. Meyer, P.A., J.L. Jones, C.Z. Garrison, and H. Dowda. 1994. Comparison of individuals receiving anonymous and confidential testing for HIV. South Med. J. 87:344-347. (Pubitemid 24098282)
19. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at www.aidsinfo.nih.gov/ ContentFiles/AdultandAdolescentGL.pdf Accessed 1/18/11.
20. Pao, D., U. Andrady, J. Clarke, G. Dean, S. Drake, M. Fisher, T. Green, S. Kumar, M. Murphy, A. Tang, S. Taylor, D. White, G. Underhill, D. Pillay, and P. Cane. 2004. Long-term persistence of primary genotypic resistance after HIV-1 seroconversion. J. Acquir. Immune Defic. Syndr. 37:1570-1573. (Pubitemid 39658194)
21. Priddy, F.H., C.D. Pilcher, R.H. Moore, P. Tambe, M.N. Park, S.A. Fiscus, M.B. Feinberg, and C. del Rio. 2007. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J. Acquir. Immune Defic. Syndr. 44:196-202. (Pubitemid 46292223)
22. Smith A, I. Miles, B. Le, T. Finlayson, A. Oster, and E. DiNenno. 2010. Prevalence and Awareness of HIV Infection Among Men Who Have Sex With Men-21 Cities, United States, 2008. Morb. Mortal. Wkly. Rep. 59:1201-1207.
23. Tesoriero, J.M., H.B. Battles, K. Heavner, S.Y. Leung, C. Nemeth, W. Pulver, and G.S. Birkhead. 2008. The effect of name-based reporting and partner notification on HIV testing in New York State. Am. J. Public Health. 98:728-735. (Pubitemid 351573696)
24. Thompson, M.A., J.A. Aberg, P. Cahn, J.S. Montaner, G. Rizzardini, A. Telenti, J.M. Gatell, H.F. Gunthard, S.M. Hammer, M.S. Hirsch, D.M. Jacobsen, P. Reiss, D.D. Richman, P.A. Volberding, P. Yeni, R.T. Schooley, and International AIDS Society-USA. 2010. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 304:321-333.
25. Wensing, A.M., D.A. van de Vijver, G. Angarano, B. Asjo, C. Balotta, E. Boeri, et al. and SPREAD Programme. 2005. Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management. J. Infect. Dis. 192:958-966.
26. Wheeler, W., K. Mahle, U. Bodnar, R. Kline, I. Hall, and M. McKenna. 2007. Antiretroviral Drug-Resistance Mutations and Subtypes in Drug-Na?̈ve Persons Newly Diagnosed with HIV-1 Infection, US, March 2003 to October 2006. Abstract presented at the 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, February 25-28. Abrstract no. 648.
27. Yerly, S., A. Rakik, S.K. De Loes, B. Hirschel, D. Descamps, F. Brun-Vezinet, and L. Perrin. 1998. Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J. Virol. 72: 3520-3523. (Pubitemid 28188646)